Page 158 - Bio Engineering Approaches to Cancer Diagnosis and Treatment
P. 158
156 CHAPTER 6 Laser-assisted cancer treatment
[67] Y. Yang, Y. Lin, D. Di, X. Zhang, D. Wang, Q. Zhao, S. Wang, Gold nanoparticle-gated
mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic
therapy, J. Coll. Interface Sci. 508 (2017) 323–331.
[68] Y. Qu, B.Y. Chu, J.R. Peng, J.F. Liao, T.T. Qi, K. Shi, et al. A biodegradable thermo-
responsive hybrid hydrogel: therapeutic applications in preventing the post-operative re-
currence of breast cancer, NPG Asia Mater. 7 (8) (2015) e207.
[69] J. Croissant, A. Chaix, O. Mongin, M. Wang, S. Clément, L. Raehm, et al. Two-photon-
triggered drug delivery via fluorescent nanovalves, Small 10 (9) (2014) 1752–1755.
[70] S.M. Ardekani, A. Dehghani, M. Hassan, M. Kianinia, I. Aharonovich, V.G. Gomes,
Two-photon excitation triggers combined chemo-photothermal therapy via doped carbon
nanohybrid dots for effective breast cancer treatment, Chem. Eng. J. 330 (2017) 651–662.
[71] G. Chen, H. Qiu, P.N. Prasad, X. Chen, Upconversion nanoparticles: design, nanochem-
istry, and applications in theranostics, Chem. Rev. 114 (10) (2014) 5161–5214.
[72] J. Liu, W. Bu, L. Pan, J. Shi, NIR-triggered anticancer drug delivery by upconverting
nanoparticles with integrated azobenzene-modified mesoporous silica, Angew. Chem.
Int. Ed. 52 (16) (2013) 4375–4379.
[73] B. Hou, B. Zheng, W. Yang, C. Dong, H. Wang, J. Chang, Construction of near infrared
light triggered nanodumbbell for cancer photodynamic therapy, J. Coll. Interface Sci. 494
(2017) 363–372.
[74] B. Hou, W. Yang, C. Dong, B. Zheng, Y. Zhang, J. Wu, et al. Controlled co-release of
doxorubicin and reactive oxygen species for synergistic therapy by NIR remote-triggered
nanoimpellers, Mater. Sci. Eng. C 74 (2017) 94–102.
[75] M. Hashemi, B. Muralidharan, M. Omidi, J. Mohammadi, Y. Sefidbakht, E.S. Kim, et al.
Effect of size and chemical composition of graphene oxide nanoparticles on optical ab-
sorption cross-section, J. Biomed. Opt. 23 (8) (2018) 085007.